Compaq's Ben Rosen To Speak At BIO '99

  • Contact: Dan Eramian or Charles Craig or Libby Mikesell
  • Phone: 202-962-9200
  • Recommend
  • Tweet
  • Print
  • Email

Washington, D.C., April 29, 1999 Compaq Computer Corp. Chairman Ben Rosen is among the featured speakers at the BIO '99 International Biotechnology Meeting and Exhibition in Seattle, May 16-20.

Rosen, a founder of Compaq, will be the keynote speaker Tuesday, May 18, at lunch, which begins at 12:10 p.m. in the ballroom of the Washington State Convention & Trade Center. Other BIO '99 keynote luncheon speakers are Washington Gov. Gary Locke, Monday, and NASA Administrator Dan Goldin, Wednesday.

At Thursday's lunch, featured speakers are patient advocates Lenny Van Pelt, of the International Patient Advocacy Association, and Lisa Wolverton-Caswell and Ray Merenstein, both of Research!America.

The annual meeting of the Biotechnology Industry Organization (BIO) is the world's largest exhibition of its kind. A record 5,000 company executives, scientists, investment experts and government officials from 40 nations are expected to attend. The conference will feature more than 125 presentations including developments in medical, agricultural and industrial biotechnology. More than 500 exhibitors also will display their most up-to-date product innovations.

Women's Health Issues Featured

Monday, May 17, will feature a full day of presentations focusing on women's health issues. A symposium titled, "Hope for the Heart: Women and Heart Disease in the New Millennium," will be held from 10 a.m. to noon and will feature leading researchers, clinicians and educators discussing advances in treating heart disease, the No. 1 killer of men and women.

Two other presentations Monday are: "An Album of Research Hope: Perspectives on Women's Health and Animal Research," 10 a.m. to 11:30 a.m.; and "Advances in Women's Health," 1:45 p.m. to 3:15 p.m.

The "Perspectives on Women's Health and Animal Research" session will feature the following speakers: Dr. Nora Disis, of the University of Washington, who has spent nine years developing a breast cancer vaccine; Dr. Cindy Pekow, of the Veterans Administration Puget Sound Health Care System, who will examine how animals are chosen for research; Alice Burgess, a breast cancer survivor and spokesperson for protocols on animal care; and Lynn O'Connell, of Americans for Medical Progress, who will discuss the first-ever national survey on women's attitudes toward medical research, animal rights and charitable giving.

The "Advances in Women's Health" session will feature the following speakers: Dr. Andrea LaCroix, of the Fred Hutchison Cancer Research Center, who will discuss women's health initiatives; Dr. Douglas Muchmore, of Eli Lilly and Co., who will talk about the osteoporosis drug, Evista; and Dr. Leslie Garrison, of Immunex Corp., who will discuss the rheumatoid arthritis drug, Enbrel.

A full program of BIO '99 symposia, presentations and events is available on BIO's web site at www.bio.org. All BIO '99 sessions will take place at the Washington State Convention & Trade Center in Seattle.

Registration for credentialed press is complimentary. Free- lance journalists must submit an assignment letter from a publication. A fully operational press room with computers and Internet access will be available. To register contact BIO's Charles Craig at (202) 962-9200.

###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.